Novartis (NYSE:NVS) shares are plunging roughly 14%, marking one of the stock's worst single-day declines on record, after the company disclosed that del-desiran (delpacibart etedirsen) failed to meet its primary endpoint in the Phase 3 HARBOR trial for myotonic dystrophy type 1. This marks …
Progyny (NASDAQ:PGNY) shares are trading sharply higher after a research firm raised its price target to $33 from $31 while maintaining its Outperform-equivalent rating, citing the company's newly announced win with CalPERS, the California Public Employees' Retirement System, which selected Progyny as its fertility …
Pharvaris (NASDAQ:PHVS) shares are trading sharply higher after the company announced statistically significant, clinically meaningful topline results from the pivotal Phase 3 CHAPTER-3 study of once-daily deucrictibant XR for the prevention of hereditary angioedema attacks. The trial met its primary endpoint with an 83% …
PROCEPT BioRobotics (NASDAQ:PRCT) shares are tumbling as mounting securities litigation continues to overhang the stock, with multiple law firms racing toward a September 22, 2026 lead plaintiff deadline in a federal class action. PROCEPT is a commercial-stage surgical robotics company focused on developing image-guided …
Roivant Sciences (NASDAQ:ROIV) shares are surging after its Pulmovant subsidiary reported strong Phase 2 PHocus results for mosliciguat in pulmonary hypertension associated with interstitial lung disease, presented at the ERS International Congress. The drug hit its primary endpoint with a placebo-adjusted 56.3% reduction in …
Director Birger Johannes Meyer-Gloeckner filed a Form 4 with the SEC on September 8, 2026, disclosing a net stock option exercise and same-day sale of ordinary shares in ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) on September 4, 2026.
Theodore Alan Huizenga, SVP and Chief Accounting Officer of Ultragenyx Pharmaceutical Inc., filed a Form 4 on September 8, 2026, disclosing a sale of common stock on September 3, 2026, related to RSU vesting.
Ronald Kyle Kettler, Chief Financial Officer of Granite Ridge Resources, Inc., filed a Form 4 on September 8, 2026, reporting a purchase of 6,000 shares of common stock on September 4, 2026.
Bruno Sousa Mauad, a director of Aura Minerals Inc. (NASDAQ:AUGO), filed a statement of changes in beneficial ownership on September 8, 2026, reporting the settlement of a cash-settled total return swap transacted on September 4, 2026.
Jeffery V. Curry, Chief Legal Officer and Secretary of CBL & Associates Properties Inc, filed a Form 4 on September 8, 2026, disclosing a sale of common stock that occurred on September 3, 2026.